AAAAAA

   
Results: 1-9 |
Results: 9
HOME NEBULIZER USE AMONG PATIENTS WITH CYSTIC-FIBROSIS
Authors: ROSENFELD M EMERSON J ASTLEY S JOY P WILLIAMSWARREN J STANDAERT TA YIM DL CRIST D THYKKUTTATHIL M TORRENCE M FITZSIMMONS S RAMSEY B
Citation: M. Rosenfeld et al., HOME NEBULIZER USE AMONG PATIENTS WITH CYSTIC-FIBROSIS, The Journal of pediatrics, 132(1), 1998, pp. 125-131
EFFECTS OF REPETITIVE USE AND CLEANING TECHNIQUES OF DISPOSABLE JET NEBULIZERS ON AEROSOL GENERATION
Authors: STANDAERT TA MORLIN GL WILLIAMSWARREN J JOY P PEPE MS WEBER A RAMSEY BW
Citation: Ta. Standaert et al., EFFECTS OF REPETITIVE USE AND CLEANING TECHNIQUES OF DISPOSABLE JET NEBULIZERS ON AEROSOL GENERATION, Chest, 114(2), 1998, pp. 577-586
EFFECT OF NEBULIZER TYPE AND ANTIBIOTIC CONCENTRATION ON DEVICE PERFORMANCE
Authors: WEBER A MORLIN G COHEN M WILLIAMSWARREN J RAMSEY B SMITH A
Citation: A. Weber et al., EFFECT OF NEBULIZER TYPE AND ANTIBIOTIC CONCENTRATION ON DEVICE PERFORMANCE, Pediatric pulmonology, 23(4), 1997, pp. 249-260
UTILIZATION OF SALIVARY CONCENTRATIONS OF CIPROFLOXACIN IN SUBJECTS WITH CYSTIC-FIBROSIS
Authors: SMITH A WEBER A PANDHER R WILLIAMSWARREN J COHEN ML RAMSEY B
Citation: A. Smith et al., UTILIZATION OF SALIVARY CONCENTRATIONS OF CIPROFLOXACIN IN SUBJECTS WITH CYSTIC-FIBROSIS, Infection, 25(2), 1997, pp. 106-108
A COMPARISON OF PEAK SPUTUM TOBRAMYCIN CONCENTRATION IN PATIENTS WITHCYSTIC-FIBROSIS USING JET AND ULTRASONIC NEBULIZER SYSTEMS
Authors: EISENBERG J PEPE M WILLIAMSWARREN J VASILIEV M MONTGOMERY AB SMITH AL RAMSEY BW BOROWITZ D EIGEN H HIATT P MOSS R KONSTAN M SCHIDLOW D WILMOTT R YEE W CRIST D JOY P MCNAMARA S GRAY D PITLICK W
Citation: J. Eisenberg et al., A COMPARISON OF PEAK SPUTUM TOBRAMYCIN CONCENTRATION IN PATIENTS WITHCYSTIC-FIBROSIS USING JET AND ULTRASONIC NEBULIZER SYSTEMS, Chest, 111(4), 1997, pp. 955-962
REPEAT ADMINISTRATION OF AN ADENOVIRUS VECTOR ENCODING CFTR TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS
Authors: ZABNER J RAMSEY BW MEEKER DP AITKEN ML BALFOUR RP GIBSON RL LAUNSPACH J MOSCICKI RA RICHARDS SM STANDAERT TA WILLIAMSWARREN J WADSWORTH SC SMITH AE WELSH MJ
Citation: J. Zabner et al., REPEAT ADMINISTRATION OF AN ADENOVIRUS VECTOR ENCODING CFTR TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS, Journal of investigative medicine, 44(3), 1996, pp. 319-319
REPEAT ADMINISTRATION OF AN ADENOVIRUS VECTOR ENCODING CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS
Authors: ZABNER J RAMSEY BW MEEKER DP AITKEN ML BALFOUR RP GIBSON RL LAUNSPACH J MOSCICKI RA RICHARDS SM STANDAERT TA WILLIAMSWARREN J WADSWORTH SC SMITH AE WELSH MJ
Citation: J. Zabner et al., REPEAT ADMINISTRATION OF AN ADENOVIRUS VECTOR ENCODING CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS, The Journal of clinical investigation, 97(6), 1996, pp. 1504-1511
NEBULIZER DELIVERY OF TOBRAMYCIN TO THE LOWER RESPIRATORY-TRACT
Authors: WEBER A SMITH A WILLIAMSWARREN J RAMSEY B COVERT DS
Citation: A. Weber et al., NEBULIZER DELIVERY OF TOBRAMYCIN TO THE LOWER RESPIRATORY-TRACT, Pediatric pulmonology, 17(5), 1994, pp. 331-339
DISPOSITION OF DRUGS IN CYSTIC-FIBROSIS .4. MECHANISMS FOR ENHANCED RENAL CLEARANCE OF TICARCILLIN
Authors: WANG JP UNADKAT JD ALHABET SMH OSULLIVAN TA WILLIAMSWARREN J SMITH AL RAMSEY B
Citation: Jp. Wang et al., DISPOSITION OF DRUGS IN CYSTIC-FIBROSIS .4. MECHANISMS FOR ENHANCED RENAL CLEARANCE OF TICARCILLIN, Clinical pharmacology and therapeutics, 54(3), 1993, pp. 293-302
Risultati: 1-9 |